Glucocorticosteroids Affect Functions of Airway- and Blood-derived Human T-cell Clones, Favoring the Th1 Profile through Two Mechanisms

American Journal of Respiratory Cell and Molecular Biology

Volumn 14, Issue 4, 1996, Pages 388-397

  Krouwels, Frans H ^b   Van Der Heijden, Jeroen F ^b   Lutter, René ^b   Joost Van Neerven, R J ^b   Jansen, Henk M ^b   Out, Theo A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; HUMAN; IMMUNOLOGY; KINETICS; LUNG LAVAGE; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE; TH1 CELL;

ANTIBODIES; ANTIGENS, CD3; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; KINETICS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TH1 CELLS;

EID: 0030117685     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.14.4.8600944     Document Type: Article

References (58)

1. Azzawi, M., B. Bradley, P. K. Jeffery, A. J. Frew, A. J. Wardlaw, G. Knowles, B. Assoufi, J. V. Collins, S. R. Durham, and A. B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142:1407-1413.
2. Walker, C., M. K. Kaegi, P. Braun, and K. Blaser. 1991. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88:935-942.
3. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
4. Ying, S., S. R. Durham, C. J. Corrigan, Q. Hamid, and A. B. Kay. 1995. Phenotype of cells expressing mRNA for TH2-type (interleukin-4 and interleukin-5) and TH1-type (interleukin-2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477-487.
5. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J.-C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
6. Ädelroth, E., L. Rosenhall, S. Johansson, M. Linden, and P. Venge. 1990. Inflammatory cells and eosinophilic activity in asthmatics, investigated by bronchoalveolar lavage Am. Rev. Respir. Dis. 142:91-99.
7. Van de Graaf, E. A., T. A. Out, C. M. Roos, and H. M. Jansen. 1991. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma; effects of therapy with inhaled steroids. Am. Rev. Respir. Dis. 143:362-368.
8. Djukanovic, R., J. W. Wilson, Y. M. Britten, S. J. Wilson, A. F. Walls, W. F. Roche, P. H. Howarth, and S. T. Holgate. 1992. Effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma. Am. Rev. Respir. Dis. 145:699-707.
9. Burke, C., C. K. Power, A. Norris, A. Condez, B. Schmekel, and L. W. Poulter. 1992. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur. Respir. J. 5:73-79.
10. Robinson, D., Q. Hamid, S. Ying, A. Bentley, B. Assoufi, S. Durham, and A. B. Kay. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am. Rev. Respir. Dis. 148:401-406.
11. 2-type cytokine gene expression at sites of allergen challenge in subjects with allergic asthma. Am. J. Respir. Crit. Care Med. 148(Part 2 of 2):A944. (Abstr.)
12. Gillis, S., G. R. Crabtree, and K. A. Smith. 1979. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J. Immunol. 123:1624-1631.
13. Arya, S. K., F. Wong-staal, and R. C. Gallo. 1984. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J. Immunol. 133:273-276.
14. Rolfe, F. G., J. M. Hughes, C. L. Armour, and W. A. Sewell. 1992. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 77:494-499.
15. Wu, C. Y., C. Fargeas, T. Nakajima, and G. Delespesse. 1991. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 21:2645-2647.
16. Daynes, R. A., and B. A. Araneo. 1989. Contrasting effects of glucocorticosteroids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19:2319-2325.
17. Snijdewint, F. G. M., M. L. Kapsenberg, P. J. J. Wauben-Penris, and J. Bos. 1995. Corticosteroids class-dependently inhibit in vitro Th1 and Th2-type cytokine production. Immunopharmacology 29:93-101.
18. Davidson, B. L., J. Faust, S. Pessano, R. P. Daniele, and G. Rovera. 1985. Differentiation and activation phenotypes of lung T-lymphocytes differ from those of circulating T-lymphocytes. J. Clin. Invest. 76:60-65.
19. Saltini, C., M. Kirby, B. C. Trapnell, N. Tamura, and R. G. Crystal. 1990. Biased accumulation of T-lymphocytes with "memory"-type CD45 leucocyte common antigen expression on the epithelial surface of the human lung. J. Exp. Med. 171:1123-1140.
20. Berman, J. S., D. J. Beer, A. C. Theodore, H. Kornfeld, J. Bernardo, and D. M. Center. 1990. Lymphocyte recruitment to the lung. Am. Rev. Respir. Dis. 142:238-257.
21. + T cells for dexamethasone. Int. Immunol. 7:591-595.
22. Hol, B. E. A., F. H. Krouwels, B. Bruinier, R. M. R. Reijneke, H. J. J. Mengelers, L. Koederman, H. M. Jansen, and T. A. Out. 1993. Cloning of T-lymphocytes from broncho-alveolar lavage fluid. Am. J. Respir. Cell Mol. Biol. 7:523-530.
23. Krouwels, F. H., B. E. A. Hol, B. Bruinier, R. Lutter, H. M. Jansen, and T. A. Out. 1995. Cytokine production by T-cell clones from bronchoalveolar lavage fluid of patients with asthma and healthy controls. Eur. Respir. J. (In press)
24. Depper, J. M., W. J. Leonard, R. J. Robb, T. A. Waldmann, and W. C. Greene. 1983. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J. Immunol. 131:690-696.
25. Hakimi, J., V. C. Ha, P. Lin, E. Campbell, M. K. Gately, M. Tsudo, P. W. Payne, T. A. Waldmann, A. J. Grant, W. Tsien and W. P. Schneider. 1993. Humanized Mik β1, a humanized antibody to the IL-2 receptor β-chain that acts synergistically with humanized anti-TAC. J. Immunol. 151:1075-1085.
26. Smith, K. A., M. F. Favata, and S. Oroszlan. 1983. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J. Immunol. 131:1808-1816.
27. Van Neerven, R. J. J., W. Van't Hof, J. H. Ringrose, H. M. Jansen, R. C. Aalberse, E. A. Wierenga, and M. L. Kapsenberg. 1993. T cell epitopes of house dust mite major allergen Der p II. J. Immunol. 151:2326-2335.
28. Van Neerven, R. J. J., M. M. Van de Pol, E. A. Wierenga, R. C. Aalberse, H. M. Jansen, and M. L. Kapsenberg. 1994. Peptide specificity and HLA restriction do not dictate lymphokine production by allergen-specific T-lymphocyte clones. Immunology 82:351-356.
29. Bruinier, B., F. H. Krouwels, B. E. A. Hol, H. M. Jansen, T. A. Out, and R. Lutter. 1994. Expression of activation markers by human lung T cells after adherence to lung epithelial cells. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 267:L543-L550.
30. Van der Meide, P. H., M. Dubbeld, and H. Schellekens. 1985. Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J. Immunol. Methods 79:293-305.
31. McNamee, L. A., D. I. Fattah, T. J. Baker, S. K. Bains, and P. H. Hissey. 1991. Production, characterisation and use of monoclonal antibodies to human interleukin-5 in an enzyme-linked immunoabsorbent assay. J. Immunol. Methods 141:81-88.
32. Martin, E., and S. Bhakdi. 1992. Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphylococcus aureus by peripheral blood leukocytes. J. Clin. Microbiol. 30:2246-2255.
33. c chain of the IL-2 receptor. Science 266:1039-1042.
34. Waldmann, T. A. 1991. The interleukin-2 receptor. J. Biol. Chem. 266: 2681-2684.
35. Takeshita, T., K. Ohtani, H. Asao, S. Kumaki, M. Nakamura, and K. Sugamura. 1992. An associated molecule, p64, with IL-2 receptor β-chain: its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. J. Immunol. 148:2154-2162.
36. Hill, M. R., S. J. Szefler, B. D. Ball, M. Bartoszek, and M. Brenner. 1990. Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin. Pharmacol. Ther. 48:390-398.
37. Dworski, R., G. A. Fitzgerald, J. A. Oates, J. R. Sheller, R. Workman, and C. Prakash. 1994. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am. J. Respir. Crit. Care Med. 149:953-959.
38. Corrigan, C. J., P. H. Brown, N. C. Barnes, S. J. Szefler, J.-J. Tsai, A. J. Frew, and A. B. Kay. 1991. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am. Rev. Respir. Dis. 144:1016-1025.
39. + subsets. J. Immunol. 155:3322-3328.
40. Schmidt, J., S. Fleissner, I. Heimann-Weitschat, R. Lindstaedt, and I. Szelenyi. 1994. The effect of different corticosteroids and cyclosporin A on interleukin-4 and interleukin-5 release from murine TH2-type T cells. Eur. J. Pharmacol. 260:247-250.
41. Guyre, P. M., M. T. Girard, P. M. Morganelli, and P. D. Manginiello. 1988. Glucocorticoid effects on the production and action of immune cytokines. J. Steroid Biochem. 30:89-93.
42. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist and A. S. Baldwin. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
43. Auphan, N., J. A. Didonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
44. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145: 3796-3806.
45. Batuman, O. A., A. P. Ferrero, A. Diaz, and S. A. Jimenez. 1991. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J. Clin. Invest. 88:1574-1580.
46. Barnes, P. J., and F. Y. Liew. 1995. Nitric oxide and asthmatic inflammation. Immunol. Today 16:128-130.
47. Di Rosa, M., M. Radomski, R. Carnuccio, and S. Moncada. 1990. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172:1246-1252.
48. Reed, J. C. 1986. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene regulation. J. Immunol. 137:150-154.
49. Wiegers, G. J., M. S. Labeur, I. E. M. Stec, W. E. F. Klinken, F. Holsboer, and J. M. H. M. Reul. 1995. Glucocorticosteroids accelerate anti-T cell receptor-induced T cell growth. J. Immunol. 155:1893-1902.
50. Nijhuis, E. W. P., B. Hinloopen, J. Odding, and L. Nagelkerken. 1994. Abrogation of the suppressive effects of dexamethasone by PKC activation or CD28 triggering. Cell. Immunol. 156:438-447.
51. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappaB and the glucocorticoid receptor. Prof. Natl. Acad. Sci. USA 91:752-756.
52. Fernández-Ruiz, E., A. Rebollo, M. A. Nieto, E. Sanz, C. Somoza, F. Ramirez, A. Lopez-Rivas, and A. Silva. 1989. IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptors. J. Immunol. 143:4146-4151.
53. Lamas, M., E. Sanz, L. Martin-Parras, E. Espel, P. Sperisen, M. Collins, and A. G. Silva. 1993. Glucocorticoid hormones upregulate interleukin 2 receptor a gene expression. Cell. Immunol. 151:437-450.
54. Pimentel-Muiños, F. X., M. A. Muñoz-Fernández, and M. Fresno. 1994. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:5714-5722.
55. Boumpas, D. T., E. D. Anastassiou, S. A. Older, G. C. Tsokos, D. L. Nelson, and J. E. Balow. 1991. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1739-1747.
56. Paliogianni, F., S. S. Ahuja, J. P. Balow, J. E. Balow, and D. T. Boumpas. 1993. Novel mechanism for inhibition of human T cells by glucocorticoids: glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 151:4081-4089.
57. Corrigan, C. J., P. H. Brown, N. C. Barnes, J.-J. Tsai, A. J. Frew, and A. B. Kay. 1991. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am. Rev. Respir. Dis. 144:1026-1032.
58. Leung, D. Y. M., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J. Exp. Med. 181:33-40.